The UMKC Health Sciences District (HSD) Research Council is focused on addressing substance use disorders (SUD) and the national opioid epidemic. Our goal is to foster collaboration between UMKC Health Sciences District members so that focused cross-disciplinary approaches to these can be developed.
We invite you to review the following list of funding opportunities that may be of interest to opioid researchers. To add other opportunities to this list, please email us: Info@UMKCHealthSciencesDistrict.org
This information is abstracted for brevity; please refer to the sponsor’s website for complete information.
Upcoming Funding Opportunities (as of Feb 7, 2019) :
NIH TITLE |
FOA |
Org |
Expires |
Activity Code |
RFA-AR-19-029 |
NIAMS |
Feb 26, 2019 |
UG3/UH3 |
|
RFA-DA-19-023 |
NIDA |
Feb 27, 2019 |
U2C |
|
RFA-HL-19-029 |
NHLBI |
Feb 27, 2019 |
U01 |
|
RFA-DA-19-024 |
NIDA |
Feb 27, 2019 |
U2C |
|
RFA-HL-19-028 |
NHLBI |
Feb 27, 2019 |
R01 |
|
RFA-DA-19-025 |
NIDA |
Feb 27, 2019 |
UG1 |
|
Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional) |
RFA-NS-19-009 |
NINDS |
Feb 28, 2019 |
R21 |
RFA-AT-19-001 |
NCCIH |
Feb 28, 2019 |
R61/R33 |
|
Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional) |
RFA-NS-19-008 |
NINDS |
Feb 28, 2019 |
R01 |
RFA-TR-19-003 |
NCATS |
Feb 28, 2019 |
UG3/UH3 |
|
RFA-TR-19-005 |
NCATS |
Feb 28, 2019 |
UH2/UH3 |
|
RFA-NS-19-010 |
NINDS |
Mar 6, 2019 |
UG3/UH3 |
|
RFA-NS-19-020 |
NINDS |
Mar 6, 2019 |
U44 |
|
RFA-DA-19-034 |
NIDA |
Mar 13, 2019 |
U24 |
|
RFA-DA-19-035 |
NIDA |
Mar 13, 2019 |
UG3/UH3 |
|
RFA-AT-19-007 |
NCCIH |
Mar 15, 2019 |
R01 |
|
RFA-AT-19-005 |
NCCIH |
Mar 15, 2019 |
UG3/UH3 |
|
RFA-AT-19-008 |
NCCIH |
Mar 15, 2019 |
R01 |
|
RFA-AT-19-009 |
NCCIH |
Mar 15, 2019 |
R21 |
|
RFA-AR-19-026 |
NIAMS |
Mar 20, 2019 |
U19 |
|
RFA-AR-19-027 |
NIAMS |
Mar 20, 2019 |
U24 |
|
RFA-AR-19-028 |
NIAMS |
Mar 20, 2019 |
UH2/UH3 |
|
RFA-DA-19-032 |
NIDA |
Mar 20, 2019 |
R41/R42 |
|
RFA-DA-19-033 |
NIDA |
Mar 20, 2019 |
R43/R44 |
|
RFA-DA-19-029 |
NIDA |
Mar 25, 2019 |
R34 |
|
RFA-DA-19-036 |
NIDA |
Mar 25, 2019 |
R34 |
|
RFA-DK-18-030 |
NIDDK |
Mar 27, 2019 |
U01 |
|
RFA-DK-18-031 |
NIDDK |
Mar 27, 2019 |
U01 |
|
RFA-HD-19-025 |
NICHD |
Mar 29, 2019 |
PL1 |
|
RFA-HS-19-001 |
AHRQ |
Mar 31, 2019 |
R18 |
|
RFA-MH-19-525 |
NIMH |
Apr 1, 2019 |
U01 |
|
PA-18-574 |
NIH |
Apr 5, 2019 |
R43/R44 |
|
PA-18-575 |
NIH |
Apr 5, 2019 |
R41/R42 |
|
PA-18-576 |
NIH |
Apr 5, 2019 |
R41/R42 |
|
PA-18-573 |
NIH |
Apr 5, 2019 |
R43/R44 |
|
PA-18-058 |
NIDA |
May 7, 2019 |
R01 |
|
PA-18-076 |
NIDA |
May 7, 2019 |
R21 |
|
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) |
PA-18-141 |
NINR |
May 7, 2019 |
R01 |
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) |
PA-18-159 |
NINR |
May 7, 2019 |
R21 |
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed) |
RFA-HD-19-024 |
NICHD |
May 14, 2019 |
R01 |
PAR-18-331 |
NIMHD |
Jun 7, 2019 |
R01 |
|
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01) |
PAR-17-484 |
NIMHD |
Dec 4, 2019 |
R01 |
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21) |
PAR-17-483 |
NIMHD |
Dec 4, 2019 |
R21 |
RFA-DA-19-002 |
NIDA |
Jan 1, 2020 |
UG3/UH3 |
|
PA-18-038 |
NICHD |
Jan 7, 2020 |
R01 |
|
PA-18-043 |
NICHD |
Jan 7, 2020 |
R21 |
|
PA-18-044 |
NICHD |
Jan 7, 2020 |
R03 |
|
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) |
PA-18-060 |
NIDA |
Jan 7, 2020 |
R01 |
Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) |
PA-18-078 |
NIDA |
Jan 7, 2020 |
R21 |
PAR-18-662 |
NCCIH |
Feb 28, 2020 |
UG3/UH3 |
|
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
PAR-18-118 |
NCCIH |
Feb 29, 2020 |
U01 |
RFA-NS-18-041 |
NINDS |
Mar 12, 2020 |
R61/R33 |
|
RFA-NS-18-046 |
NINDS |
Mar 12, 2020 |
R61/R33 |
|
Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21) |
PA-17-157 |
NIDA |
May 7, 2020 |
R21 |
Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01) |
PA-17-155 |
NIDA |
May 7, 2020 |
R01 |
PA-18-061 |
NIDA |
May 7, 2020 |
R01 |
|
PA-18-079 |
NIDA |
May 7, 2020 |
R21 |
|
PA-18-080 |
NIDA |
May 7, 2020 |
R03 |
|
RFA-DA-19-003 |
NIDA |
Jul 17, 2020 |
R61/R33 |
|
Assay development and screening for discovery of chemical probes or therapeutic agents (R01) |
PAR-17-438 |
NCI |
Sep 7, 2020 |
R01 |
PAR-18-417 |
NCCIH |
Sep 7, 2020 |
R34 |
|
PAS-18-624 |
NIDA |
Sep 7, 2020 |
R01 |
|
PAS-18-625 |
NIDA |
Sep 7, 2020 |
R21 |
|
PAR-18-745 |
NIMHD |
Nov 13, 2020 |
R21 |
|
PAR-18-747 |
NIMHD |
Nov 13, 2020 |
R01 |
|
NINDS Exploratory Clinical Trials for Small Business (R44) – Clinical Trial Required |
PAR-18-618 |
NINDS |
Jan 5, 2021 |
R44 |
NINDS Exploratory Clinical Trials for Small Business (R42) – Clinical Trial Required |
PAR-18-617 |
NINDS |
Jan 5, 2021 |
R42 |
PA-18-775 |
NIDA |
Jan 7, 2021 |
R34 |
|
PA-18-591 |
NIH |
Jan 25, 2021 |
(Admin Supp) |
|
PAR-18-742 |
NIDA |
Feb 11, 2021 |
R61/R33 |
|
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) |
RFA-NS-19-016 |
NINDS |
Feb 22, 2021 |
UG3/UH3 |
HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional) |
RFA-NS-19-017 |
NINDS |
Feb 22, 2021 |
U44 |
HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional) |
RFA-NS-19-018 |
NINDS |
Feb 22, 2021 |
UH3 |
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed) |
RFA-EB-18-003 |
NIBIB |
Feb 22, 2021 |
U18 |
PAR-18-506 |
NICHD |
May 7, 2021 |
R01 |
|
Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) |
PA-18-660 |
NIAAA |
May 7, 2021 |
R01 |
PA-18-687 |
NICHD |
May 7, 2021 |
R03 |
|
PA-18-688 |
NICHD |
May 7, 2021 |
R01 |
|
PA-18-773 |
NIDA |
May 7, 2021 |
R01 |
|
PA-18-780 |
NIDA |
May 7, 2021 |
R34 |
|
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) |
PAS-18-915 |
NIDA |
Sep 7, 2021 |
R01 |
PA-18-917 |
NIDA |
Sep 7, 2021 |
R01 |
|
RFA-DA-19-019 |
NIDA |
Sep 8, 2021 |
R43/R44 |
|
RFA-DA-19-020 |
NIDA |
Sep 8, 2021 |
R41/R42 |
|
PAR-19-039 |
NINDS |
Sep 14, 2021 |
U01 |
|
PAR-19-040 |
NINDS |
Sep 14, 2021 |
U01 |
|
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
PAR-19-064 |
NIDA |
Nov 8, 2021 |
R21 |
PAR-19-100 |
NCATS |
Nov 9, 2021 |
R21 |
|
PAR-19-099 |
NCATS |
Nov 9, 2021 |
U01 |
|
PA-18-932 |
ODP |
Jan 7, 2022 |
R01 |
|
PA-18-946 |
NINR |
Jan 7, 2022 |
R21 |
|
PA-18-945 |
NINR |
Jan 7, 2022 |
R01 |
|
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) |
PA-18-943 |
NINR |
Jan 7, 2022 |
R21 |
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) |
PA-18-944 |
NINR |
Jan 7, 2022 |
R01 |
PAR-19-045 |
NINR |
Jan 7, 2022 |
R01 |
|
PAR-19-044 |
NINR |
Jan 7, 2022 |
R21 |
UMKC Health Sciences District Research Council members
Dr. Jinwen Cai, Kansas City, Missouri Health Department
Dr. Kathy Goggin, Children’s Mercy Hospital
Dr. Mark Hecker, UMKC School of Medicine
Dr. Jessica Hellings, Truman Medical Centers Behavioral Health
Dr. Jianwei Jiao, Center for Behavioral Medicine
Dr. Joseph Lightner, UMKC School of Nursing and Health Studies
Dr. Russell Melchert, UMKC School of Pharmacy
Dr. Paula Monaghan-Nichols, UMKC School of Medicine
Dr. Mark Nichols, UMKC School of Medicine
Dr. Mark Steele, Truman Medical Centers
Dr. Mary Walker, UMKC School of Dentistry